Biomarkers and coptis chinensis activity for rituximab-resistant diffuse large B-cell lymphoma: Combination of bioinformatics analysis, network pharmacology and molecular docking

CONCLUSION: This study revealed biomarkers and Coptis chinensis-associated molecular functions for rituximab-resistant DLBCL.PMID:38517810 | DOI:10.3233/THC-230738
Source: Technology and Health Care - Category: Medical Devices Authors: Source Type: research